Neuoleptic-related sudden death (proven or a mere hypothesis?).

Abstract

There are sound theoretical, practical and ethical reasons why, in keeping with the progress of psychopharmacotherapy, the possibility of sudden death during neuroleptic therapy should be periodically reexamined. 11935 patients were treated with neuroleptics at our c1inic over aperiod of eleven years (I. January 1968-3 I. December 1978); eight of them died suddenly and unexpectedly. The sudden death mortality rate of medicated patients was not higher than that of the general population of the same age distribution.